GHTC was quoted in an article in Financial Times (FT) reporting on the US government's withdrawal from the World Health Organization (WHO).
View
GHTC released the following statement following the US Administration's action to begin formally withdrawing from the World Health Organization (WHO).
Learn more
GHTC joined a letter endorsed by nearly 350 public health organizations urging Secretary of Health and Human Services (HHS) Alex Azar to support the critical role of the Centers for Disease Control and Prevention (CDC) in the United States' COVID-19 response. The letter expresses concern that evidence-based public health messages from the agency have been disregarded or silenced in the response, and it calls for increased funding for CDC's core budget.
View
GHTC endorsed a call to action to world leaders urging additional funding and support for the development and implementation of COVID-19 diagnostics.
View
GHTC submitted feedback on white paper released by Senator Lamar Alexander (R-TN), chair of the Senate Health, Education, Labor and Pensions Committee, outlining proposals to shape pandemic preparedness legislation to be considered by the committee this year. GHTC provided a number of policy recommendations to strengthen the health R&D ecosystem, including improving coordination between R&D agencies and increasing funding for R&D for naturally-occurring threats at the Biomedical Advanced Research and Development Authority.
PDF
GHTC released the following statement in advance of the Global Goal: Unite for Our Future Summit on June 27.
Learn more
GHTC has opened nominations for its 2020 Innovating for Impact Awards. Now in its fourth year, this initiative celebrates the partnerships and policymakers driving global health innovation. The nomination deadline is July 31, 2020.
Learn more
A letter endorsed by GHTC's director Jamie Bay Nishi calling for greater investment in research on COVID-19 diagnostics through the ACT Accelerator was featured in Politico Europe's Morning Health Care newsletter.
Learn more